| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/02/1997 | EP0765668A1 Extract of Iridaceas and composition containing it |
| 04/02/1997 | EP0765667A1 Ribosomal fraction and composition containing it |
| 04/02/1997 | EP0765326A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 04/02/1997 | EP0765305A1 Anti-inflammatory compounds |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765152A1 Stimulation of hair growth by peptide-copper complexes |
| 04/02/1997 | EP0765151A1 Antibacterial oil-in-water emulsions |
| 04/02/1997 | EP0679087B1 Cosmetic or pharmaceutical and particularly dermatological composition containing a vismia extract |
| 04/02/1997 | EP0668853B1 Succinic acid derivatives for use as skin conditioners |
| 04/02/1997 | EP0656773B1 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions |
| 04/02/1997 | EP0576456B1 Pharmaceutical compositions for the treatment of skin disorders |
| 04/02/1997 | EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same |
| 04/02/1997 | CN1146725A Gel for treatment of skin diseases and for disinfection of the skin |
| 04/02/1997 | CN1146353A Capsule and ointment for skin diseases |
| 04/02/1997 | CN1146338A Stable cross-linked compound of polyvinyl pyrrolidone and iodine and method for preparation of said compound |
| 04/01/1997 | US5616614 Useful in treatment of disorders linked to abnormal melatonin activity |
| 04/01/1997 | US5616602 Skin disorders |
| 04/01/1997 | US5616596 Substituted arylalkynyl-and heteroarylalkynl-N-hydroxyurea inhibitors of leukotriene biosynthesis |
| 04/01/1997 | US5616572 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy |
| 04/01/1997 | US5616335 Mixture of organic peroxy acid, copolymeric ethylene oxide-propylene oxide thickener and isocyanate, for applying to human or animal skins or mucous membranes |
| 03/29/1997 | CA2186717A1 Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 03/27/1997 | WO1997011174A1 Cyclin depenpent kinase binding compounds |
| 03/27/1997 | WO1997011056A1 Indole derivatives as melatoninergic analogues |
| 03/27/1997 | WO1997010840A1 Anti-inflammatory antisense drug |
| 03/27/1997 | WO1997010838A1 Use of one or more peptides in a cosmetic composition or for the preparation of a medicament |
| 03/27/1997 | WO1997010808A1 Lipoic acid in topical compositions |
| 03/27/1997 | WO1997010712A1 Inhibition of tumor necrosis factor alpha |
| 03/27/1997 | WO1997004788A3 Use of calendula glycosides for the treatment of psoriasis |
| 03/27/1997 | WO1996029974A3 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 03/26/1997 | EP0764637A2 2-Cyano-3-mercaptocrotonamides |
| 03/26/1997 | EP0764444A1 Use of at least one peptide in a cosmetic composition or for the preparation of a medicine |
| 03/26/1997 | EP0764441A1 Cosmetic or dermopharmaceutical patch containing at least one active agent, particularly an unstable one in an oxidative medium, and at least one hydroabsorbent in an anhydrous polymeric matrix |
| 03/26/1997 | EP0764166A1 Corticotropin releasing factor antagonists |
| 03/26/1997 | EP0764162A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 03/26/1997 | EP0649405B1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs |
| 03/26/1997 | EP0535067B1 Endonucleases |
| 03/26/1997 | CN1146153A Use of ginsenoside Ro or plant extract containing same to promote collagen synthesis |
| 03/26/1997 | CN1145779A Medicine matrix and its use |
| 03/25/1997 | US5614556 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
| 03/25/1997 | US5614514 Steroid esters |
| 03/25/1997 | US5614513 Release agent binder for vitamin d compounds and derivatives |
| 03/25/1997 | US5614215 Liposomes, psoriasis, acne, dermatitis, antiaging, antiwrinkling, moisturizers |
| 03/25/1997 | US5614208 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 03/25/1997 | US5614171 Hydrophilic pharmaceutical composition containing ketoprofen lysine salt for topical use |
| 03/25/1997 | CA1339007C Collagen wound healing matrices and process for their production |
| 03/20/1997 | WO1997010254A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | WO1997010196A1 Products extracted from a plant of the genus commiphora, particularly the commiphora mukul plant, extracts containing same and applications thereof, for example in cosmetics |
| 03/20/1997 | WO1997009990A1 Transdermal therapeutical system for silatran compounds |
| 03/20/1997 | WO1997009987A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 03/20/1997 | WO1997009975A1 Topical anti-skin-cancer preparations |
| 03/20/1997 | WO1997009974A1 Antiseptic skin care composition and method for making same |
| 03/20/1997 | WO1997009960A1 Composition and method for treating diseased nails |
| 03/20/1997 | DE19534201A1 Zubereitung zur Prophylaxe und/oder Behandlung von Woll- und Haarausfall Preparation for the prophylaxis and / or treatment of wool and hair loss |
| 03/20/1997 | CA2232089A1 Oligomers which inhibit expression of collagen genes |
| 03/20/1997 | CA2232081A1 Antiseptic skin care composition and method for making same |
| 03/20/1997 | CA2232026A1 Transdermal therapeutical system for silatran compounds |
| 03/20/1997 | CA2231769A1 Composition and method for treating diseased nails |
| 03/20/1997 | CA2185850A1 2-cyano-3-mercaptocrotonamides |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763362A2 A pharmaceutical base in ointment form and its use |
| 03/19/1997 | EP0763052A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0762868A1 Mild antimicrobial liquid cleansing formulations |
| 03/19/1997 | EP0667770B1 Inhibition of tnf production |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145359A Application of salicylic acid derivative used as oil-in-water emulsion |
| 03/18/1997 | US5612367 Method of enhancing bioavailability of pharmaceutical agents |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612356 Retinoid antagonists |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612325 Antiinflammatory and immunomodulating effects |
| 03/18/1997 | US5612324 Method for treating acne |
| 03/18/1997 | US5612038 Product with lipolytic activity and its method of preparation |
| 03/18/1997 | CA2076980C Method and product for promoting hair growth and treating skin conditions |
| 03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
| 03/13/1997 | WO1997009427A1 Vegf-related protein |
| 03/13/1997 | WO1997009307A1 Retinoylamide based derivatives of sphingoid bases |
| 03/13/1997 | WO1997009298A1 Production of an immunosuppressant using microorganisms |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
| 03/13/1997 | WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract |
| 03/13/1997 | WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 03/13/1997 | WO1997001343A3 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin |
| 03/13/1997 | WO1996039372A3 Macrophage lipid chemoattractant |
| 03/13/1997 | DE19533330A1 Gegen Hautkrebs wirksame topische Zubereitungen Against skin cancer effective topical preparations |
| 03/13/1997 | CA2231400A1 Vegf-related protein |
| 03/12/1997 | EP0761661A1 Glycomimetics as selectin antagonists, and anti-inflammatory agents prepared thereof |
| 03/12/1997 | EP0761228A2 Gamma interferon containing composition for treatment of prurigo |
| 03/12/1997 | EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them |
| 03/12/1997 | EP0761095A2 A new skin preparation composition |
| 03/12/1997 | EP0760819A1 Tricyclic dicarbonyl derivatives |
| 03/12/1997 | EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists |
| 03/12/1997 | EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 03/12/1997 | EP0760650A1 Antimicrobial oil-in-water emulsions |
| 03/12/1997 | EP0648207B1 Vitamin d analogues |
| 03/12/1997 | CN1145031A Starch-metal complexes for skin and hair |
| 03/12/1997 | CN1145029A Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them |
| 03/12/1997 | CN1144671A "Antixin" and its preparation method |
| 03/11/1997 | US5610302 Composition intended for use for retarding hair loss and for inducing and stimulating its growth, containing 2-aminopyrimidine 3-oxide derivatives, and new compounds derived from 2-aminopyrimidine 3-oxide |
| 03/11/1997 | US5610196 Methyl unsaturated long-chain alkyl ketone, acne |